Although neurotransplantation of primary fetal cells into the striatum of patients with Parkinson’s disease (PD) has been reported to be effective, poor clinical outcome and severe side effects lower clinical long-term results. A major drawback of cell replacement therapies in PD is the low cell survival and lacking regeneration of the neuronal circuitries due to the ectopic transplantation of cells into the host striatum. More anatomic and functional integration could potentially be reached by an orthotopic cell transplantation into their natural position within the rostral mesencephalon at the site of the Substantia nigra, where dopaminergic cells get lost in PD. The aim of the thesis was to provide the scientific basis for the use of injectable bioscaffols containing chemo-attractants promoting cell survival, differentiation and axo-dendritic outgrowth of dopaminergic cells. With the so called “bridging” transplantation technology an artificial axon pathway between the substantia nigra and the striatum with targeted nigro-striatal re-innervation should be generated. Thereby, the central dopaminergic nigro-striatal pathway would be reconstructed enabling a fully integration of grafted neurons into the basal ganglia circuitries. The main focus of the thesis was to explore the influence of bioscaffolds on cell survival and morphology of dopaminergic neurons in vitro. The investigations included isolation of primary fetal mesencephalic cells and fetal mesencephalic neural stem cells (NSCs) from embryonic (E14) mouse brain and their culture on ECM compounds and starPEG-heparin hydrogels. Initial characterizations of the gels showed separate as well as simultaneous immobilization and release of growth factors demonstrating that hydrogels could serve as an efficient storage and delivery system for growth factors. The axo-dendritic outgrowth of dopaminergic cells including primary branching, total branching and neurite elongation; cell survival studies; cell type analysis and cell migration were analyzed by immunostaining. Both cell sources showed distinct growth properties depending on the stiffness of the gel material and the presence of biomolecules with increased cell survival by the presence of RGD and FGF-2 in the hydrogel independent of network characteristic. Moreover, the presence of RGD on hydrogels was found to initiate differentiation of NSCs, whereas FGF-2 bound to hydrogels was shown to promote the viability of undifferentiated cells. Additionally, survival and axo-dendritic outgrowth of dopaminergic cells were observed to be affected by the gel properties: RGD or FGF-2 modification of hydrogels with intermediate network density showed the best results for dopaminergic growth. With the addition of GDNF to hydrogels the total amount of cells decreased strongly by an equal quantity of dead cells compared to FGF-2 bound hydrogels. Furthermore, differential effects were found for the survival of different brain cells depending on the growth factor which is loaded. GDNF was found to increase the survival of astrocytes, whereas FGF-2 bound to gels stimulated the viability of oligodendrocyte precursor cells. No differential effects were found for the survival of NSCs and mature neuronal cells on GDNF or FGF-2 bound gels. By showing the penetration of primary fetal mesencephalic cells expressing MMPs as endogenous endopeptidases into MMP-cleavable hydrogels, the potential biodegradability of the starPEG-heparin hydrogels was demonstrated. Together the findings provide the in vitro proof-of-principle data for combining dopaminergic neurons or predopaminergic NSCs with biomaterials for reconstructing the central dopaminergic nigro-striatal pathway by the “bridging” transplantation strategy as an alternative transplantation approach in PD. Further studies should focus on three-dimensional cell culture studies using starPEG-heparin hydrogels with cleavable peptide sequences and their functionalization with gradients of axon guidance molecules to selectively promote dopaminergic outgrowth.

Since decades, hematopoietic stem cell transplantation (HSCT) has become a well established treatment modality for hematological malignancies and non-malignant disorders. Autologous and allogeneic hematopoietic stem cells (HSCs) mobilized into the peripheral blood (PB) have been used as a preferred source of transplantable stem cells1-3. And umbilical cord blood (UCB) has been introduced as a more attractive HSC source for HSCT, because fetal stem cells in UCB are speculated to be more primitive in comparison to adult stem cells. However the limited amount of HSCs is limiting their application for stem cell therapy in clinic. Therefore, people started to utilize extra-embryonic tissue to harvest more fetal stem cells, while people also tried to optimize the clinical protocol to mobilize more adult stem cells out of adult bone marrow. The innovative strategies and feasible procedures were discussed in this thesis. The axis of the chemokine receptor CXCR4 and its ligand SDF-1 is important for trafficking and homing of HSCs. It has already been demonstrated that the bicyclam AMD3100, a CXCR4 antagonist, in combination with G-CSF is able to induce a significant mobilization of CD34+ cells4. And human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development5. The homing of HSCs to the placenta is probably also mediated by the expression of SDF-1 as demonstrated for the bone marrow niche. In this study (part 1 of the chapter “Results and discussions”), we utilized AMD3100 to mobilize HSCs from placenta. And we can demonstrate that the CXCR4 antagonist AMD3100 mobilise placenta derived CD34+ cells ex utero already after 30 min of incubation and may further enhance the efficacy of harvesting placenta-derived HSC. The alpha4 integrin CD49d is involved in migration and homing of hematopoietic stem cells (HSC). Therapeutic application of natalizumab, an anti-CD49d antibody, in patients with multiple sclerosis (MS) has been associated with increased levels of circulating CD34+ progenitors. In our study (part 2 of the chapter “Results and discussions”), we compared circulating HSCs from MS patients after natalizumab treatment and HSCs mobilized by G-CSF in healthy volunteers, with regard to their migratory potential, clonogenicity and gene expression. CD34+ cells in the blood and marrow of natalizumab-treated patients expressed less of the stem cell marker CD133, were enriched for erythroid progenitors (CFU-E) and expressed lower levels of adhesion molecules. The level of surface CXCR-4 expression on CD34+ cells from patients treated with natalizumab was higher compared to that of CD34+ cells mobilized by granulocyte-colony stimulating factor (G-CSF) (median 43.9% vs. 15.1%). This was associated with a more than doubled migration capacity towards a chemokine stimulus. Furthermore, CD34+ cells mobilized by natalizumab contained more m-RNA for p21 and less MMP9 compared to G-CSF mobilised HSC. Our data indicate that G-CSF and CD49d blockade mobilize different HSC subsets and suggest that both strategies may be differentially applied in specific cell therapy approaches. In order to further improve the clinical outcome of HSC transplantation, many groups are focusing on ex vivo maintain or expand HSC. Unfortunately, the maintenance of HSC in vitro is difficult to achieve because of their differentiation. This is presumably caused by a lack of appropriate cues that are provided in vivo by the microenvironment. Indeed, HSCs located in the bone marrow are interacting with a specific microenvironment referred to as the stem cell niche, which regulates their fate in terms of quiescence, self-renewal and differentiation. An orchestra of signals mediated by soluble factors and/or cell-to-cell contact keeps the balance and homeostasis of self-renewal, proliferation and differentiation in vivo. To investigate the communication between HSCs and the niche, coculture assays with mesenchymal stromal cells (MSCs) were performed in vitro. Here, we can demonstrate that cell-to-cell contact has a significant impact on hematopoietic stem cells expansion, migratory potential and stemness. In this study (part 3 of the chapter “Results and discussions”), we investigated in more detail the spatial relationship between hematopoietic stem cells and mesenchymal stromal cells during ex-vivo expansion. And we defined three distinct localizations of HSCs relative to MSC layer: (i) those in supernatant (non-adherent cells); (ii) cells adhering on the surface of mesenchymal stromal cells (phase-bright cells) and (iii) cells beneath the mesenchymal stromal cells (phase-dim cells). Our data suggest that the mesenchymal stromal cell surface is the dominant location where hematopoietic stem cells proliferate, whereas the compartment beneath the mesenchymal stromal cell layer seems to be mimicking the stem cell niche for more immature cells. Our data provide novel insight into the construction and function of three-dimensional HSC–MSC microenvironments. In summary, we provided a new method to isolate fetal stem cells from extra-embryonic tissue (i.e. placenta) in the first part, then we discussed an innovative strategy with CD49d blockade to improve clinical modality for adult stem cell mobilization in the second part, and finally we investigated HSC maintenance and expansion in vitro and provided feasible way to mimic HSC niche in vitro in the last part. This thesis contributes to HSC-based stem cell therapy in two aspects, i.e. 1) fetal and adult stem cell isolation holding great therapeutic potential for blood diseases; 2) ex vivo stem cell manipulation providing a valuable platform to model HSC niche regulation.

During development, organs with different shape and functionality form from a single fertilized egg cell. Mechanisms that control shape, size and morphology of tissues pose challenges for developmental biology. These mechanisms are tightly controlled by an underlying signaling system by which cells communicate to each other. However, these signaling networks can affect tissue size and morphology through limited processes such as cell proliferation, cell death and cell shape changes,which are controlled by cell mechanics and cell adhesion. One example of such a signaling system is the network of interacting proteins that control planar polarization of cells. These proteins distribute asymmetrically within cells and their distribution in each cell determines of the polarity of the neighboring cells. These proteins control the pattern of hairs in the adult Drosophila wing as well as hexagonal repacking of wing cells during development. Planar polarity proteins also control developmental processes such as convergent-extension. We present a theoretical study of cell packing geometry in developing epithelia. We use a vertex model to describe the packing geometry of tissues, for which forces are balanced throughout the tissue. We introduce a cell division algorithm and show that repeated cell division results in the formation of a distinct pattern of cells, which is controlled by cell mechanics and cell-cell interactions. We compare the vertex model with experimental measurements in the wing disc of Drosophila and quantify for the first time cell adhesion and perimeter contractility of cells. We also present a simple model for the dynamics of polarity order in tissues. We identify a basic mechanism by which long-range polarity order throughout the tissue can be established. In particular we study the role of shear deformations on polarity pattern and show that the polarity of the tissue reorients during shear flow. Our simple mechanisms for ordering can account for the processes observed during development of the Drosophila wing.

β-Carboline sind heterozyklische Indolalkaloide, die ubiquitär in unserer Umwelt und Nahrung vorkommen, aber auch endogen aus Tryptophan gebildet werden können. Aufgrund der strukturellen Verwandtschaft bestimmter β-Carboline zu dem dopaminergen Neurotoxin MPP+ wird ein möglicher Beitrag zur Pathogenese der Parkinson-Krankheit diskutiert. MPP+ ist seit langem für seine selektive Toxizität gegenüber dopaminergen Neuronen und das Auslösen von Parkinsonsymptomen bekannt. Insbesondere 2,9-DiMe-BC wurde in erhöhter Konzentration in der lumbalen cerebrospinalen Flüssigkeit von Parkinsonpatienten detektiert, jedoch nicht in Kontrollprobanden. Eine Inhibierung von Komplex I der mitochondrialen Atmungskette und eine selektive Toxizität auf DA Neurone konnten nachgewiesen werden. Die genauen Mechanismen des Zelltodes bleiben jedoch ungeklärt. Im Rahmen dieser Arbeit wurden die Mechanismen des Zelltodes, ausgelöst durch 2,9-DiMe-BC, in dopaminergen Primärzellkulturen des Mesencephalons von C57Bl/6-Mäusen untersucht. Drei weitere BC 2-Me-BC, 9-Me-BC und 1,9-DiMe-BC standen für Untersuchungen zur Verfügung. In ersten Experimenten wies 9-Me-BC und 1,9-DiMe-BC keine Toxizität gegenüber DA Neuronen auf. Aufgrund der höheren Toxizität von 2,9-DiMe-BC verglichen mit 2-Me-BC wurden nachfolgende Experimente mit dem zweifach methylierten BC durchgeführt. Durch die Behandlung mit 2,9-DiMe-BC konnte ein höherer Verlust der DA Neurone gegenüber anderen neuralen Zellen festgestellt werden. Eine selektive Aufnahme über den Dopamintransporter und damit verbundene Schädigung der DA Neurone, wie bei MPP+, konnte nicht nachgewiesen werden. Für 2,9-DiMe-BC wurde eine LC50 der DA Neurone von 14,1 µM und für MPP+ von 4,4 µM bestimmt. 2,9-DiMe-BC verursachte in der Gesamtkultur eine erhöhte Entstehung von reaktiven Sauerstoffspezies und eine gesteigerte Laktatproduktion. In diesem Zusammenhang kann eine Hemmung von Komplex I der Atmungskette vermutet werden. Des Weiteren konnte eine Verringerung des mitochondrialen Membranpotentials und des ATP-Gehaltes gemessen werden. Eine Aktivierung des apoptotischen Zelltodes wurde mit einer erhöhten Aktivität von Caspase-3 nachgewiesen. Durch die Behandlung mit 2,9-DiMe-BC wurde in der Primärzellkultur jedoch auch in erhöhtem Maß Nekrose ausgelöst. Dabei wurde eine höhere Sensitivität von jüngeren Kulturen (8. DIV) gegenüber älteren (10. DIV) festgestellt. Genexpressionsanalysen konnten das Auslösen von oxidativem Stress und Apoptose durch 2,9-DiMe-BC bestätigen, da mehrere Gene dieser Prozesse hochreguliert wurden. Des Weiteren wurden Gene reguliert, die im Zusammenhang mit der Hitzeschock-Antwort, Entzündungsprozessen, DNA-Schädigung und Reparatur, Zellalterung und Proliferation stehen. Zusammenfassend lässt sich sagen, dass 2,9-DiMe-BC die Mitochondrienaktivität hemmt, sowohl nekrotische als auch apoptotische Prozesse in der dopaminergen mesencephalen Primärzellkultur auslöst und die Entstehung von oxidativem Stress eine zentrale Rolle spielt. Der zweite Teil dieser Arbeit beschäftigte sich mit der Untersuchung von unerwarteten neuroprotektiven Effekten von 9-Me-BC in der Primärzellkultur. Durch die Behandlung mit 9-Me-BC verringerte sich die LDH-Freisetzung und reduzierte sich die Anzahl der nekrotischen Zellen um 50 %. Nach 24 h konnte eine verminderte Caspase 3-Aktivität gemessen werden, die allerdings nach 48 h im Vergleich zur Kontrolle wieder zunahm. Hier wären längerfristige Untersuchungen zur Klärung dieser Frage anzuschließen. Des Weiteren erhöhte sich der intrazelluläre ATP-Gehalt. Möglicherweise fand eine energieabhängige Verschiebung von Nekrose zu Apoptose statt. Genexpressionsanalysen zeigten, dass verschiedene Gene von inflammatorischen und apoptotischen Signaltransduktionswegen herrunterreguliert wurden. Überraschenderweise erhöhte sich nach der Behandlung mit 9-Me-BC die Anzahl DA Neurone konzentrationsabhängig um bis zu 20 %. Diese Beobachtung ist neu und wurde über noch kein anderes BC berichtet. Der Effekt wurde durch die Inhibierung des DAT aufgehoben und lässt eine DAT-abhängige Aufnahme von 9-Me-BC vermuten. Die signifikante Erhöhung der Anzahl beschränkte sich nur auf DA Neurone, während sich der Gesamtanteil der Neurone nur geringfügig erhöhte und die übrigen Zellen unbeeinflusst blieben. Zusätzlich wurden ein erhöhter intrazellulärer DA-Gehalt und eine gesteigerte Aufnahme von [3H]DA um 20 % nachgewiesen. Die [3H]DA-Aufnahme und morphologische Untersuchungen zeigten funktionale und reife DA Neurone, es wurde aber auch die Theorie der Neuentstehung durch mögliche Differenzierungsprozesse untersucht. Interessanterweise wurde die Genexpression von einem breiten Spektrum neurotropher Faktoren (Shh, Wnt1, Wnt5a) und Transkriptionsfaktoren (En1, Nurr1, Pitx3), die für die Differenzierung und Entwicklung DA Neurone entscheidend sind, durch die Behandlung mit 9-Me-BC hochreguliert. Zusätzlich erhöhte sich die Expression der DA Markergene Aldh1a1, Dat und Th. Dabei war die Hochregulierung der Genexpression bei allen Faktoren bis auf Shh und Wnt1 von der Anwesenheit des BC abhängig. Ein weiterer Aspekt, der auf eine Differenzierung hindeuten könnte, war die verringerte Anzahl mitotischer BrdU-positiver Zellen. Das Erscheinen DA Neurone könnte also auf Differenzierung und Entwicklung von undifferenzierten Zellen oder Vorläuferzellen beruhen. Jedoch wäre auch eine Induktion der TH von vorher TH-negativen Zellen denkbar. Eine weitere Erklärung könnte das Vorherrschen eines dynamischen Gleichgewichts von Absterben und Neuentstehung DA Neurone innerhalb der Primärzellkultur sein und der Absterbeprozess durch protektive Effekte von 9-Me-BC unterbunden wurde. Zukünftige Experimente sollten zu einer weiteren Aufklärung, der diesem Phänomen zu Grunde liegendenen Mechanismen beitragen. Auch durch die Behandlung mit dem Harman 1,9-DiMe-BC erhöhte sich die Anzahl der DA Neurone konzentrationsabhängig, jedoch erwies sich im Vergleich zu 9-Me-BC nur eine Konzentration von 50 µM als signifikant. Innerhalb dieser Arbeit wurden auf Genexpressionsebene mit Hilfe von Microarrays und qRT-PCR mögliche neuroprotektive Effekte des Dopaminagonisten Lisurid im gleichen Zellkulturmodell untersucht. Lisurid gehört zur Substanzklasse der Ergotalkaloide und wird zur Behandlung der Parkinson-Krankheit eingesetzt. Bei Voruntersuchungen in der DA mesencephalen Primärzellkultur wies Lisurid eine protektive Wirkung für DA Neurone gegen Glutamattoxizität auf. Durch qRT-PCR konnten nur 50 % der ausgewählten Gene der Microarraydaten validiert werden. Nach 24 h Behandlung mit Lisurid wurde die Genexpression von dem Transportprotein Transthyretin (Ttr) hochreguliert, dessen erhöhte Biosynthese und Sekretion interessanterweise mit einer Verminderung der Aggregation des Amyloid-β-Proteins assoziiert wird. Die Genexpression der Aldoketoreduktase 1c20 (Ark1c20) wurde um 50 % herrunterreguliert. Die Bedeutung dieses Ergebnisses bedarf weiterer Abklärung, da eine gewebspezifische Expression bisher nur für die Leber gefunden wurde. Das Thyroidhormonrezeptorbindende Protein 3 (Thrap3), die Mitogen aktivierte Kinase Kinase Kinase 12 (Map3k12) und der G-Protein gekoppelte Rezeptor 27 (Gpr27) waren in ihrer Genexpression hochreguliert. Ein Einfluss von Lisurid auf Signaltransduktionswege konnte somit nachgewiesen werden. Des Weiteren wurde durch Lisurid die Expression der Transkriptionsfaktoren NeuroD1 und Tcf3 hochreguliert, die in Differenzierungsprozesse involviert sind. NeuroD1 gilt dabei als proneurales Gen und ist somit möglicherweise an Vorgängen der Neuroprotektion beteiligt. Keines der validierten differentiell exprimierten Gene des 24 h Experimentes war nach einem Behandlungszeitraum von 6 h reguliert. Die Änderungen der Genexpression nach Preinkubation mit Lisurid und anschließender Glutamatbehandlung und Behandlung mit Glutamat allein überschnitten sich weitestgehend. Demnach war vor allem die Glutamatbehandlung für die differentielle Genexpression verantwortlich. Eine zusätzliche Neusynthese von radikalfangenden Proteinen durch Preinkubation mit Lisurid konnte auf Genebene nicht gefunden werden. Es ist jedoch nicht auszuschließen, da eine Regulation auf post-transkriptioneller Ebene möglich ist.

The discovery of resetting human somatic cells via introduction of four transcription factors into an embryonic stem cell-like state that enables the generation of any cell type of the human body has revolutionized the field of medical science. The generation of patient-derived iPSCs and the subsequent differentiation into the cells of interest has been, nowadays, widely used as model system for various inherited diseases. The aim of this thesis was to generate iPSCs and to subsequently derive NPCs which can be differentiated into neurons in order to model the two most common forms of the NCLs: LINCL which is caused by mutations within the TPP1 gene, encoding a lysosomal enzyme, and JNCL which is caused by mutations within the CLN3 gene, affecting a lysosomal transmembrane protein. It was shown that patient-derived fibroblasts can be successfully reprogrammed into iPSCs by using retroviral vectors that introduced the four transcription factors POU5F1, SOX2, KLF4 and MYC. The generated iPSCs were subsequently differentiated into expandable NPCs and finally into mature neurons. Phenotype analysis during the different stages, namely pluripotent iPSCs, multipotent NPCs and finally differentiated neurons, revealed a genotype-specific progression of the disease. The earliest events were observed in organelle disruption such as mitochondria, Golgi and ER which preceded the accumulation of subunit c of the mitochondrial ATPase complex that was only apparent in neurons. However, none of these events led to neurodegeneration in vitro. The established disease models recapitulate phenotypes reported in other NCL disease models such as mouse, dog and sheep model systems. More importantly, the hallmark of the NCLs, accumulation of subunit c in neurons, could be reproduced during the course of disease modeling which demonstrates the suitability of the established system. Moreover, the derived expandable NPC populations can be used for further applications in drug screenings. Their robust phenotypes such as low levels of TPP1 activity in LINCL patient-derived NPCs or cytoplasmic vacuoles, containing storage material, observed in CLN3 mutant NPCs, should serve as possible phenotypic read-outs.

The structure and functions of lipid rafts and the mechanisms of intracellular membrane trafficking are major topics in current cell biological research. Rafts have been proposed to act as sorting platforms during biosynthetic transport, especially along pathways that deliver proteins to the apical membrane of polarised cells. Based on this, the aim of this work was to contribute to the understanding of apical sorting in epithelial cells. The study of how lipid rafts are structured has been hampered by the scarcity of techniques for their purification. Rafts are thought to be partially resistant to solubilisation by mild detergents, which has made the isolation of detergent-resistant membranes (DRMs) the primary method to characterise them biochemically. While a growing number of detergents is being used to prepare DRMs, it is not clear what can be inferred about the native structure of cell membranes from the composition of different DRMs. This issue was addressed by an analysis of DRMs prepared with a variety of mild detergents. The protein and lipid content of different DRMs from two cell lines, Madin-Darby canine kidney (MDCK) and Jurkat cells, was compared. It was shown that the detergents differed considerably in their ability to selectively solubilise membrane proteins and lipids. These results make it unlikely that different DRMs reflect the same underlying principle of membrane organisation. Another obstacle for understanding apical sorting is that the evidence implicating certain proteins in this process has come from various disparate approaches. It would be helpful to re-examine the putative components of the apical sorting machinery in a single experimental system. To this end, a retroviral system for RNA interference (RNAi) in MDCK cells was established. Efficient suppression of thirteen genes was achieved by retroviral co-expression of short hairpin RNAs and a selectable marker. In addition, the system was extended to simultaneously target two genes, giving rise to double knockdowns.Retroviral RNAi was applied to deplete proteins implicated in apical sorting. Surprisingly, none of the knockdowns analysed caused defects in surface delivery of influenza virus hemagglutinin, a common marker protein for apical transport. Therefore, none of the proteins examined is absolutely required for transport to the apical membrane of MDCK cells. Cells may adapt to the depletion of proteins involved in membrane trafficking by activating alternative pathways. To avoid such adaptation, a visual transport assay was established. It is based on the adenoviral expression of fluorescent marker proteins whose surface transport can be followed microscopically as soon as RNAi has become effective. With this assay, it should now be possible to screen the knockdowns for defects in surface transport. Taken together, this work has provided a number of experimental tools for the study of membrane trafficking in epithelial cells. First, the biochemical analysis of DRMs highlighted that DRMs obtained with different detergents are unlikely to correspond to distinct types of membrane microdomains in cell membranes. Second, the retroviral RNAi system should be valuable for defining the function of proteins, not only in membrane transport, but also in processes like epithelial polarisation. Third, the visual assay for monitoring the surface transport of adenovirally expressed marker proteins should be suitable to detect defects in polarised sorting.

Microtubules are a part of the cell cytoskeleton that performs different functions, such as providing the mechanical support for the shape of a cell, acting as tracks along which the motor protein move organelles from one part of the cell to another, or the forming mitotic spindle during the cell division. The microtubules are dynamic structures, namely they can grow and shrink. The phase of microtubule growth alternates with the phase of shrinkage that results in the dynamic microtubule network in the cell. However, to form stable and spatially well-defined structures, such as a mitotic spindle, the cell needs to control this stochastic process. This is done by microtubule-associated proteins (MAPs). One class of MAPs is the proteins of XMAP216/Dis1 family, which are microtubule polymerases. The founding member of this family is X. laevis XMAP215. XMAP215 is a processive polymerase acting on the microtubule plus end. XMAP215 binds either directly or reaches the microtubule plus end by the diffusion along the microtubule lattice. Being at the microtubule plus-end XMAP215 stays there transiently and helps to incorporate up to 25 tubulin dimers into microtubule lattice before it dissociates and, therefore, it processively tracks the growing microtubule end during polymerization. There are two hypothesis of microtubule assembly promotion: (i) XMAP215 repeatedly releases an associated tubulin dimer into the microtubule growing plus end or (ii) structurally stabilizes a polymerized tubulin intermediate at the growing plus end and, therefore, preventing depolymerization events. The first way results into the increase of on-rate of tubulin dimers at the microtubule end, whereas the second way results into the decrease of off-rate of tubulin dimers at the microtubule end. Here, I show the study of the mechanism of microtubule growth acceleration by XMAP215 and the dependence of XMAP215 polymerization activity on the applied force. To answer these questions, I investigated the addition of tubulin dimers to the plus end of the microtubule by XMAP215 and how this addition depends on the applied force. XMAP215 remains at the microtubule end for several rounds of tubulin addition surfing both growing and shrinking microtubule ends. Therefore, if one could track the position of the XMAP215 molecules at the very tip of a microtubule with sufficient resolution, it would provide the information about the dynamics of the microtubule end. The technique, which can detect the position of the object of interest with high spatial and temporal resolution in addition to being able to exert a force, is an optical trap. A calibrated optical trap not only provides a good measure of displacement but also enables force measurements. To monitor the position of the molecules of interest, the molecules of interest are usually attached to a microsphere. Hence, I tethered XMAP215 to a microsphere held by an optical trap, and used XMAP215 as a handle to interact with the microtubule tip. When the microtubule grows, the XMAP215 coated microsphere will move in the optical trap and this movement can be detected with high temporal and spatial resolution. My work demonstrates that cooperatively working XMAP215 molecules can not only polymerize microtubule but also harness the energy of microtubule polymerization or depolymerization to transport some cargo. There is an evidence that orthologues of XMAP215 in budding yeasts, fission yeasts and Drosophila localize on the kinetochores. Therefore, the ability of the bearing some load during microtubule polymerization could be potentially important for the XMAP215 functioning during cell division. I also showed the influence of external force applied to the XMAP215 molecules. Pointing toward microtubule growth, a force of 0.5 pN applied to the microtubule tip-coupled XMAP215-coated microsphere increases XMAP215 polymerization activity. However, the force of the same magnitude but applied against microtubule growth does not affect XMAP215 polymerization activity. This result can be explained by the fact, that the force acting in the direction of microtubule growth constrains XMAP215 to be at the very microtubule tip. Hence, XMAP215 can not diffuse away from plus-end and there is higher chance to incorporate tubulin dimers into the microtubule plus-end. The on- and off-rate of tubulin dimers at the microtubule end are both decreased when the external force applied either in direction of microtubule growth or opposite to it. The external force affects the off-rate slightly stronger than on-rate of tubulin dimer. Taking together, my study gives new insights into the mechanism of microtubule polymerization by XMAP215 and shows some novel properties of this protein.

The high composition of fruits and vegetables in the daily diet is associated with cognitive well-being, especially in the elderly population. The phytonutrients are shown to have effects as antioxidants that neutralize oxidative stressors and can interact with molecular pathways to signal neuron survival. Adult hippocampal neurogenesis is a dynamic lifelong process of generating functional newborn neurons in the granular layer of the dentate gyrus from adult precursor cells. This process contributes to brain plasticity and plays a role in learning and memory. External stimuli such as environmental enrichment and physical activity are known to positively regulate this process. However, the role of nutrition and whether nutritional compounds have pro-neurogenic effects on adult hippocampal precursor cells are still elusive. In this study, I investigated the impact of dietary compounds in apples, a significant source of phytonutrients in our food, on adult hippocampal neurogenesis. I demonstrated that quercetin, the most abundant polyphenol in apple, induces cell cycle exit and differentiation of adult hippocampal precursor cells in monolayer culture. Furthermore, this compound also increases the number of surviving cells upon differentiation in vitro, through the activation of endogenous antioxidants in the Nrf2-Keap1 pathway and the prosurvival Akt pathway. Quercetin supplementation in vivo is also shown to significantly increase the number of surviving cells and new neurons in the dentate gyrus. To search for other potential active compounds in apple, I performed bioassay-guided fractionation whereby the flesh extract from apples of the Pinova cultivar was subjected to liquid- and solid phase separation and the active fraction was determined using primary neurosphere assays using cells derived from adult mouse dentate gyrus. Using mass spectometry, we revealed that the active compounds in the apple flesh extract are dihydroxybenzoate glycosides, which are non-flavonoid benzoic acid derivatives. I also confirmed that the isomers of these compounds; 2,3- and 3,5 dihydroxybenzoic acids significantly increase the number of neurospheres. Interestingly, 3,5 dihdroxybenzoic acid is an agonist of lactate receptor hydroxycarboxylic acid receptor 1 (HCAR1), with an even higher affinity than lactate. This receptor is suggested to mediate neurotrophic actions such as increasing production and release of BDNF. I also demonstrated for the first time that this receptor is presence in adult hippocampal precursor cells. To observe whether customary fruits or fruit-related products consumption affects adult hippocampal neurogenesis, I performed an experiment giving apple juice supplementation ad libitum to mice. I did not find a significant increase in net neurogenesis or the performance in the Morris water maze after apple juice supplementation. This is likely due to the low concentration of active compounds in apple juice failing to reach an effective concentration in the body. I conclude that apples provide potential proneurogenic compounds that can influence adult hippocampal neurogenesis through the activation of endogenous antioxidant mechanisms and molecular pathways for cell survival. Further studies are necessary to investigate the role of HCAR1 activation on adult hippocampal neurogenesis, which is a potential new mechanism to explain the health benefits of fruit and vegetable consumption. / Eine Ernährung die täglich reich an Obst und Gemüse ist, hat insbesondere bei älteren Menschen einen positiven Einfluss auf kognitive Fähigkeiten. Pflanzeninhaltsstoffe wirken als natürliche Antioxidantien, indem sie oxidative Stressoren neutralisieren. Weiterhin beeinflussen pflanzliche Nährstoffe molekulare Signalwege welche beim Überleben von Neuronen eine Rolle spielen. Die adulte hippocampale Neurogenese ist ein dynamischer, lebenslanger Prozess, bei dem aus Vorläuferzellen funktionelle neue Neuronen in der Körnerzellschicht des Gyrus dentatus gebildet werden. Dieser Prozess trägt zur Plastizität des Gehirns bei und spielt eine bedeutende Rolle beim Lernen und für das Gedächtnis. Externe Stimuli wie zum Beispiel eine reizreiche Umgebung und körperliche Aktivität wirken als positive Regulatoren und begünstigen die adulte hippocampale Neurogenese. Welche Rolle die Ernährung dabei spielt und ob Nahrungsbestandteile einen proneurogenen Effekt auf adulte hippocampale Vorläuferzellen haben ist kaum bekannt. In diesem Projekt habe ich den Effekt von Nahrungsbestandteilen aus Äpfeln, welche eine bedeutende Quelle von pflanzlichen Nährstoffen in unserer Ernährung darstellen, auf die adulte hippocampale Neurogenese untersucht. Ich habe gezeigt, dass Querzetin, das am reichlichsten in Äpfeln enthaltende Polyphenol, in der Monolayer-Zellkultur den Austritt aus dem Zellzyklus induziert und die Differenzierung von adulten hippocampalen Vorläuferzellen fördert. Des Weiteren steigert Querzetin nach der Differenzierung in vitro die Anzahl an überlebenden Zellen. Dies geschieht durch die Aktivierung von endogenen Antioxidantien des Nrf2-Keap1-Signalweges und des für das Überleben von Zellen förderlichen Akt-Signalweges. Die Verabreichung von Querzetin in vivo als Nahrungsergänzungsmittel führte ebenfalls zu einem signifikanten Anstieg der Anzahl an überlebenden Zellen und neu gebildeten Nervenzellen im Gyrus dentatus. Um weitere potentiell aktive Wirkstoffe von Äpfeln zu bestimmen, habe ich eine Bioassay-ausgerichtete Fraktionierung durchgeführt, wobei der Fruchtfleischextrakt von Äpfeln der Sorte Pinova einer Fest-/ Flüssig-Separation unterzogen wurde. Die aktive Fraktion wurde anhand der primären Neurosphäre-Assay-Methode mit Zellen aus dem Gyrus dentatus adulter Mäuse ermittelt. Mittels spektrometrischer Analyse habe ich gezeigt, dass die aktiven Wirkstoffe im Fruchtfleischextrakt von Äpfeln zur Gruppe der Dihydroxybenzol-Glykosiden gehören, welche den nicht-flavonoiden Benzoesäure-Derivaten zuzuordnen sind. Im in vitro Neurosphäre-Assay habe ich zudem gezeigt, dass die Isomere dieser Wirkstoffe, die 2,3- und die 3,5-Dihydroxybenzoesäuren, die Anzahl der Neurosphären signifikant erhöhen. Interessanterweise ist die 3,5-Dihydroxybenzoesäure ein Agonist des Laktatrezeptors Hydroxycarboxylic acid receptor 1 (HCAR1) und weist sogar eine noch höhere Affinität als Laktat auf. Es wird suggeriert, dass dieser Rezeptor neurotrophische Wirkungen vermittelt, wie zum Beispiel eine erhöhte Produktion von BDNF und dessen Ausschüttung. Zudem habe ich das Vorkommen dieses Reporters erstmalig bei adulten hippocampalen Vorläuferzellen nachgewiesen. Um zu untersuchen, ob der Konsum handelsüblicher Obstprodukte die adulte hippocampale Neurogenese beeinflusst, habe ich Mäusen Apfelsaft ad libitum verabreicht. Nach der Gabe von Apfelsaft sah ich keinen signifikanten Anstieg der Gesamtneurogenese und keine Verbesserung der Leistungsfähigkeit im Morris-Wasserlabyrinth-Test. Dies ist bedingt durch eine zu geringe Konzentration der aktiven Wirkstoffe im Apfelsaft wodurch die wirksame Konzentration im Körper nicht erreicht wird. Ich schlussfolgere, dass in Äpfeln potentielle pro-neurogene Inhaltsstoffe enthalten sind, welche die adulte hippocampale Neurogenese beeinflussen. Dies wird insbesondere durch die Aktivierung endogener antioxidativer Mechanismen und molekularer Signalwege vermittelt, die für das Überleben von Zellen von Bedeutung sind. Weitere Studien sind nötig, um zu bestimmen wie sich die Aktivierung von HCAR1 auf die adulte hippocampale Neurogenese auswirkt. Dies stellt einen potentiellen neuen Wirkmechanismus dar, welcher die gesundheitlichen Vorteile von Obst- und Gemüsekonsum belegt.

As graft source for lymphoma or leukemia treatment, hematopoietic stem and progenitor cells (HSPCs) have been the focus of translational medicine for decades. HSPCs are defined by their self-renewing capacity and their ability to give rise to all mature blood cells. They are found anchored to a specialized microenvironment in the bone marrow (BM) called the hematopoietic niche. HSPCs can be enriched by sorting them based on the presence of the surface antigen CD34 before clinical or tissue engineering use. As these cells represent a minority in most graft sources and the amount of applicable cells is limited, ex vivo expansion-cultures were established using cytokine cocktails or small molecules. However, in vitro culture of HSPCs as suspension-cultures result in heterogeneous cell populations with undefined cellular identities. In the BM niche, HSPCs are not exclusively maintained by cytokines but also by cell-matrix adhesions mediated by integrins (ITGs). Thus, β1 and β2 ITGs were found to promote initial contact of HSPCs with mesenchymal stromal cells (MSCs) and ITGβ3 expression was shown to be a marker for long-term repopulating HSPCs in vivo. Consequently, ex vivo remodeling of the BM niche using co-cultures of HSPCs and niche cells like MSCs came into spotlight and was proven to be a promising tool for stem cell expansion. However, in clinical and research applications, direct contact of two cell populations necessitates HSPC post-culture purification. To address these problems, we established a novel culture method for remodeling the BM extra cellular stroma in vitro wherein we used decellularized extracellular matrix (ECM) scaffolds derived from immortalized mesenchymal stromal cells (SCP-1). Such scaffolds were found to be highly reproducible and served as in vitro niche for HSPCs by being more effective for the expansion of CD34+ cells, compared to classical suspension cultures. ECMs were shown to consist of multiple proteins including fibronectins, collagens, and a major niche chemokine responsible for BM homing and retention of HSPCs in vivo, namely, stromal derived factor 1 (SDF-1). SDF-1 is known to be secreted by MSCs and is anchored to matrix proteins. This reveals that ECM scaffolds produced by SCP-1 cells are a naïve reconstructed microenvironment. When CD34+ cells were seeded, only around 20% of the cells adhered to the provided ECM scaffold. These cells recognized SDF-1 via C-X-C chemokine receptor type 4 (CXCR-4), as shown by laser scanning confocal microscopy. Thus, adhesive sides as they are present in the BM niche are provided. However, CD34+ cells isolated from G-CSF mobilized peripheral blood of healthy donors were found to be heterogenous with respect to adhesion capacity. Nonetheless, it was similar to HSPC co-cultures with SCP-1 cells as feeder layer. Therefore, we separated and analyzed two cell fractions, the adherent (AT-cells) and the non- adherent supernatant (SN-cells) cells. Other signals provided by the BM extracellular stroma to HSPCs are physical cues that control HSPC fate. HSPCs sense these physical features through focal contacts and accordingly remodel their morphological and biomechanical properties. Using real-time deformability cytometry (RT-DC) to uncover biomechanical phenotypes of freshly isolated HSPCs, SN-cells, AT-cells, and classical suspension cultured HSPCs in plastic culture dishes (PCD) were analyzed. We found freshly isolated cells to be less deformable and small. AT-cells displayed actin polymerization to stress fibers, and exhibited a stiffer mechanical phenotype compared to PCD-cultured or SN-cells. This might constitute the first hint of functional adaptation. Integrins are known to establish mechanosensing focal contacts. Thus, we analyzed ITG surface expression and identified ITGαIIb, ITGαV, and ITGβ3 to be enriched on AT-cells compared to freshly isolated cells or SN-cells. Active integrins need to form heterodimers consisting of one α- and one β subunit. Interestingly, the identified ITGs exclusively interact with each other to form RGD peptide receptors. RGD is a tripeptide consisting of the amino acids arginine, glycine, and aspartic acid and was identified as an adhesion sequence within fibronectin and other extracellular proteins. Consequently, we could confirm an important role for ITGαVβ3 in HSPC- ECM interaction with respect to adhesion and migration. However, we also identified ITGβ3 expression on a subset of CD34+ cells either freshly isolated or ECM cultured cells, as a marker for erythrocyte differentiation. These findings demonstrate that, in vitro, the ECM compartment acts as a regulator of HSPC fate and portray mechanical recognition as a potent driver of differentiation. In this context, targeted modulation of ECM scaffolds could enhance cell-ECM interactions and accelerate stem cell expansion or differentiation. These modulations could also provide further insights into HSPC-niche regulation. We demonstrate that ECMs derived from osteogenic differentiated SCP-1 cells increase HSPC expansion but do not lead to increased cell adhesion. As ECM adhesion preliminary alters HSPC function, we aimed at developing ECM scaffolds with increased adhesion capacity. Using lentiviral transduction, we generated a stable knock down of fibulin-1 in SCP-1 cells. Fibulin-1 is an ECM protein known to form anti-adhesion sites with fibronectin. However, we failed to increase adherent cell numbers or enhance HSPC expansion in the fibulin-1 knock down ECMs. Taken together, SCP-1 cell-derived ECM protein scaffolds provide an in vitro niche for HSPCs capable of stem cell expansion. Integrin mediated signaling altered the biomechanical and functional properties of HSPCs and hints at suspension cultures as being inappropriate to study the physiological aspects of HSPCs. Targeted modulation of ECM scaffolds could theoretically generate suitable ex vivo environments with the capacity to gain detailed insight into HSPC regulation within their niche. This will enhance the functionality of new biomaterials and will lead to improved regenerative therapies like BM transplantation.

Axolotl uniquely generates blastema cells as a pool of progenitor/stem cells to restore an entire limb, a particular property that other organisms, such as humans, do not have. What underlies these differences? Is the main difference that cells residing at the amputation plane (in the stump) undergo reprogramming processes to re-enter the embryonic program, which allows developmental patterning to start, or are there fundamental differences? There is also a significant debate about whether regeneration occurs via stem cell differentiation or by dedifferentiation of mature limb tissue. The aim of my thesis was to address following questions: Are the cells in the blastema reprogrammed or differentiated to regenerate? Are the blastema cells genetically reactivated de novo during regeneration? How does the amputated limb exactly know which part of the limb needs to be regenerate? Using a novel technique of long-term genetic fate mapping, my team demonstrated that dedifferentiation in regenerated axolotl muscle tissue does not occur. Instead, PAX7+ satellite cells indeed play an important role during muscle regeneration in the axolotl limb. Surprisingly, this is in contrast to the newt, which regenerates muscle cells through a dedifferentiation process. Therefore, there is a fundamental difference that underlies the regenerative mechanism ((Sandoval-Guzman et al., 2014) [KR1]). This demonstrates that there is an unexpected diversity and flexibility of cellular mechanims used during limb regeneration, even among two closely related species. Finally, if one salamander species uses a mammalian regenerative strategy (Cornelison and Wold, 1997; Collins et al., 2005) involving stem cells and another uses a dedifferentiative strategy, this raises the question of whether there are other fundamental aspects of regeneration that could also be anomalous. This hypothesis is promising since there could be more than one possible mechanism to induce mammalian regeneration. The process of limb regeneration in principle seems to be more similar to those of limb development as historically assumed. We showed molecularly that embryonic players are reused during regeneration by reactivating the position- and tissue-specific developmental gene programs by using the newly isolated Twist sequences as early blastema cell markers ((Kragl et al., 2013) [KR2]). To gain insights into the molecular mechanisms of the P/D limb patterning in general, it was crucial to study the early patterning events of the resident progenitor/stem cells by using the specific blastema cell marker HoxA as a positional marker along the proximo-distal axis. Our HOXA protein analysis using high molecular and cellular resolution as well as transplantation assays demonstrated for the first time that axolotl limb blastema cells acquire their positional identity in a proximal to distal sequence. We found a hierarchy of cellular restrictions in positional identities. Amputation at the level of the upper arm showed that the blastema harbors cells, which convert to lower arm and hand. We observed ((Roensch et al., 2013) [KR3]) for the first time that intercalation- the intermediate element (lower arm) arises later from an interaction between the proximal and distal cells identities- does not occur. Intercalation, which has been an accepted model for a long time, is not the patterning mechanism underlying normal (without any manipulation) limb regeneration that is unique to axolotl. We further demonstrated, using the Hox genes as markers that positional identity is cell-type specific since their effects were confirmed to be present in the lateral plate mesoderm- derived cells of the limb. As our knowledge about limb blastemas expands concerning cell composition and molecular events controlling patterning, the similarity to development is becoming more and more clear. My work has resolved many ambiguities surrounding the molecularly identification of different types of blastema cells and how P/D limb patterning occurs during regeneration in comparison to development. It has highlighted the importance of combining high-resolution methods, such as in situ hybridizations, single-cell PCR (sc-PCR) of individual dissociated blastema cells and genetic labeling methods with grafting experiments to map cell fates in vivo. In addition to understanding the processes of regeneration, another long-term goal in the regenerative medicine field is to identify key molecules that trigger the regeneration of tissues. Recently, my colleague Takuji Sugiura (Sugiura et al., 2016) observed that an early event of blastema formation is the secretion of molecules like MLP (MARCKS-like protein), which induces wound-associated cell cycle re-entry. Such findings further increase the enthusiasm of biologists to understand the underlying principles of regeneration. By building our knowledge of the molecules and pathways that are involved in tissue regeneration, we increase the possibility of identifying a way to ‘activate’ regenerative processes in humans and thus reach the final goal of regenerative medicine, which is to use the concepts of cellular reprogramming, stem cell biology and tissue engineering to repair complex body structures.